Cover

Current and Future Management of Brain Metastasis

Editor(s): Kim D.G. (Seoul) 
Lunsford L.D. (Pittsburgh, Pa.) 
Table of Contents
Vol. 25, 2012
Section title: Understanding Brain Metastasis
Kim DG, Lunsford LD (eds): Current and Future Management of Brain Metastasis. Prog Neurol Surg. Basel, Karger, 2012, vol 25, pp 13–29
(DOI:10.1159/000331167)

Epidemiology of Central Nervous System Metastases

Alexandru D. · Bota D.A. · Linskey M.E.
Departments of aNeurological Surgery and bNeurology, University of California, Irvine, Calif., USA

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Brain metastases are overwhelmingly the most common type of brain tumor, out numbering primary brain tumors in incidence by more than four-to-one. They are associated with poor prognosis both from a length-of-life as well as a quality-of-life standpoint. Once the brain metastasis is detected, without treatment, most patients die within months, either from widespread systemic disease, or due to the brain metastasis itself. The complications of brain metastases are also devastating. Patients can suffer from seizures, weakness or paralysis, language and communication deficits, as well as cognitive decline. These complications negatively impact on quality of life through effects on functional independence, impairment of capacity to participate in activities and relationships, as well as distortion of individual personality and identity. At the same time, there are great financial burdens associated with both the care and treatment of patients with brain metastases. Early detection of brain metastases in cancer patients is critical for limiting these complications, minimizing these burdens and improving the outlook regarding both survival and quality of life. Understanding the epidemiology of brain metastases can lead to the development of new strategies for the early identification and successful treatment of these patients.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Pelletier EM, Shim B, Goodman S, Amonkar MM: Epidemiology and economic burden of brain metastases among patients with primary breast cancer: results from a US claims data analysis. Breast Cancer Res Treat 2008;108:297-305
  2. Sul J, Posner JB: Brain metastases: epidemiology and pathophysiology. Cancer Treat Res 2007;136:1-21
  3. Guomundsson KR: A survey of tumors of the central nervous system in Iceland during the 10-year period 1954-1963. Acta Neurol Scand 1970;46:538-552
  4. Percy AK, Elveback LR, Okazaki H, Kurland LT: Neoplasms of the central nervous system: epidemiologic considerations. Neurology 1972;22:40-48
  5. Fogelholm R, Uutela T, Murros K: Epidemiology of central nervous system neoplasms: a regional survey in Central Finland. Acta Neurol Scand 1984;69:129-136
  6. Walker AE, Robins M, Weinfeld FD: Epidemiology of brain tumors: the national survey of intracranial neoplasms. Neurology 1985;35:219-226
  7. Posner JB, Chernik NL: Intracranial metastases from systemic cancer. Adv Neurol 1978;19:579-592
  8. Pickren JW, Lopez G, Tsukada Y, et al: Brain metastases: an autopsy study. Cancer Treat Symp 1983;2:295-313
  9. Takakura K, Sano K, Hojo S, Hirano A: Metastatic Tumors of the Central Nervous System. Tokyo, Igaku-Shoin, 1982;
  10. Shojania KG, Burton EC, McDonald KM, Goldman L: Changes in rates of autopsy-detected diagnostic errors over time: a systematic review. JAMA 2003;289:2849-2856
  11. Gavrilovic IT, Posner JB: Brain metastases: epidemiology and pathophysiology. J Neurooncol 2005;75:5-14
  12. Tham YL, Sexton K, Kramer R, Hilsenbeck S, Elledge R: Primary breast cancer phenotypes associated with propensity for central nervous system metastases. Cancer 2006;107:696-704
  13. Davis FG, McCarthy B, Jukich P: The descriptive epidemiology of brain tumors. Neuroimaging Clin Ν Am 1999;9:581-594
  14. Johnson JD, Young B: Demographics of brain metastasis. Neurosurg Clin Ν Am 1996;7:337-344
  15. Larcos G, Maisey MN: FDG-PET screening for cerebral metastases in patients with suspected malignancy. Nucl Med Commun 1996;17:197-198
  16. Fogarty GB, Tartaguia C: The utility of magnetic resonance imaging in the detection of brain metastases in the staging of cutaneous melanoma. Clin Oncol (R Coll Radiol) 2006;18:360-362
  17. Seute T, Leffers P, Wilmink JT, ten Velde GP, Twijnstra A: Response of asymptomatic brain metastases from small-cell lung cancer to systemic first-line chemotherapy. J Clin Oncol 2006;24:2079-2083
  18. Miles DW, Chan A, Dirix LY, et al: Phase III study of bevacizumab plus docetaxel compared with placebo plus docetaxel for the first-line treatment of human epidermal growth factor receptor 2-negative metastatic breast cancer. J Clin Oncol 2010;28:3239-3247
  19. Lassman AB, DeAngelis LM: Brain metastases. Neurol Clin 2003;21:1-23vii
  20. Barnholtz-Sloan JS, Sloan AE, Davis FG, Vigneau FD, Lai P, Sawaya RE: Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncol 2004;22:2865-2872
  21. Schouten LJ, Rutten J, Huveneers HA, Twijnstra A: Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer 2002;94:2698-2705
  22. Madajewicz S, Karakousis C, West CR, Caracandas J, Avellanosa AM: Malignant melanoma brain metastases: review of Roswell Park Memorial Institute experience. Cancer 1984;53:2550-2552
  23. Daryanani D, Plukker JT, de Jong MA, et al: Increased incidence of brain metastases in cutaneous head and neck melanoma. Melanoma Res 2005;15:119-124
  24. Gabos Z, Sinha R, Hanson J, et al: Prognostic significance of human epidermal growth factor receptor positivity for the development of brain metastasis after newly diagnosed breast cancer. J Clin Oncol 2006;24:5658-5663
  25. Hutter A, Schwetye KE, Bierhals AJ, McKinstry RC: Brain neoplasms: epidemiology, diagnosis, and prospects for cost-effective imaging. Neuroimaging Clin Ν Am 2003;13:237-250x-xi
  26. Nussbaum ES, Djalilian HR, Cho KH, Hall WA: Brain metastases: histology, multiplicity, surgery, and survival. Cancer 1996;78:1781-1788
  27. Bartelt S, Lutterbach J: Brain metastases in patients with cancer of unknown primary. J Neurooncol 2003;64:249-253
  28. Polyzoidis KS, Miliaras G, Pavlidis N: Brain metastasis of unknown primary: a diagnostic and therapeutic dilemma. Cancer Treat Rev 2005;31:247-255
  29. Nishizaki T, Saito K, Jimi Y, et al: The role of cyberknife radiosurgery/radiotherapy for brain metastases of multiple or large-size tumors. Minim Invasive Neurosurg 2006;49:203-209
  30. Delattre JY, Krol G, Thaler HT, Posner JB: Distribution of brain metastases. Arch Neurol 1988;45:741-744
  31. Patchell RA, Tibbs PA, Walsh JW, et al: A randomized trial of surgery in the treatment of single metastases to the brain. Ν. Engl J Med 1990;322:494-500
  32. Linskey ME, Andrews DW, Asher AL, et al: The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 2010;96:45-68
  33. Facure NO, Facure JJ: Intracerebral hematoma in metastatic tumors: report of 11 cases. Arq Neuropsiquiatr 1981;39:42-49
  34. Yoo H, Jung E, Nam BH, et al: Growth rate of newly developed metastatic brain tumors after thoracotomy in patients with non-small cell lung cancer. Lung Cancer 2011;71:205-208
  35. Pouessel D, Culine S: High frequency of intracerebral hemorrhage in metastatic renal carcinoma patients with brain metastases treated with tyrosine kinase inhibitors targeting the vascular endothelial growth factor receptor. Eur Urol 2008;53:376-381
  36. Lecumberri B, Alvarez-Escola C, Martin-Vaquero P, et al: Solitary hemorrhagic cerebellar metastasis from occult papillary thyroid microcarcinoma. Thyroid 2010;20:563-567
  37. Kobayashi T, Kida Y, Yoshida J, Shibuya N, Kageyama N: Brain metastasis of choriocarcinoma. Surg Neurol 1982;17:395-403
  38. Niazi TN, Forester C, Afify Z, Riva-Cambrin J: Osteosarcoma presenting as hemorrhagic cerebellar metastasis. Childs Nerv Syst 2009;25:1643-1647
  39. Balaji R, Ramachandran K, Kusumakumari P: Neuroimaging patterns of central nervous system metastases in neuroblastoma: report of 2 recent cases and literature review. J Child Neurol 2009;24:1290-1293
  40. Oyama H, Nakayama M, Ikeda A, et al: A case of cardiac myxoma with multiple brain hemorrhage. No Shinkei Geka 2001;29:533-537
  41. Pimentel J, Fernandes AC, Silva R, Ferro J, Cattoni B: Brain metastases of a malignant fibrous histiocytoma presenting as an acute cerebral hemorrhage. Clin Neuropathol 2001;20:64-69
  42. Redmond AJ, Diluna ML, Hebert R, et al: Gamma Knife surgery for the treatment of melanoma metastases: the effect of intratumoral hemorrhage on survival. J Neurosurg 2008;109:(suppl)99-105
  43. Waki F, Ando M, Takashima A, et al: Prognostic factors and clinical outcomes in patients with leptomeningeal metastasis from solid tumors. J Neurooncol 2009;93:205-212
  44. Chamberlain MC: Leptomeningeal metastases: a review of evaluation and treatment. J Neurooncol 1998;37:271-284
  45. Grossman SA, Krabak MJ: Leptomeningeal carcinomatosis. Cancer Treat Rev 1999;25:103-119
  46. Glass JP Melamed M, Chernik NL, Posner JB: Malignant cells in cerebrospinal fluid (CSF): the meaning of a positive CSF cytology. Neurology 1979;29:1369-1375
  47. Meyer PC, Reah TG: Secondary neoplasms of the central nervous system and meninges. Br J Cancer 1953;7:438-448
  48. Laigle-Donadey F, Taillibert S, Mokhtari K, Hildebrand J, Delattre JY: Dural metastases. J Neurooncol 2005;75:57-61
  49. Zebrowski A, Wilson L, Lim A, Stebbing J, Krell J: Intramedullary spinal cord metastases in breast cancer are associated with improved longer-term systemic control. Future Oncol 2010;6:1517-1519
  50. Chamberlain MC, Eaton KD, Fink JR, Tredway T: Intradural intramedullary spinal cord metastasis due to mesothelioma. J Neurooncol 2010;97:133-136
  51. Endo M, Hamano M, Watanabe K, Wakai S: Combined chronic subdural and acute epidural hematoma secondary to metastatic hepatocellular cancer: case report. No Shinkei Geka 1999;27:331-334
  52. Cheng YK, Wang TC, Yang JT, Lee MH, Su CH: Dural metastasis from prostatic adenocarcinoma mimicking chronic subdural hematoma. J Clin Neurosci 2009;16:1084-1086
  53. Cheng CL, Greenberg J, Hoover LA: Prostatic adenocarcinoma metastatic to chronic subdural hematoma membranes: case report. J Neurosurg 1988;68:642-644
  54. Bhargava P, McGrail KM, Manz HJ, Baidas S: Lung carcinoma presenting as metastasis to intracranial meningioma: case report and review of the literature. Am J Clin Oncol 1999;22:199-202
  55. Campbell LV, Jr, Gilbert E, Chamberlain CR, Jr, Watne AL: Metastases of cancer to cancer. Cancer 1968;22:635-643
  56. Doron Y, Gruszkiewicz J: Metastasis of invasive carcinoma of the breast to an extradural meningioma of the cranial vault. Cancer 1987;60:1081-1084
  57. Wessel H, Gerlach H: Metastases of a breast cancer to an acoustic neurinoma. Zentralbl Allg Pathol 1973;117:146-151
  58. Wong TW, Bennington JL: Metastasis of a mammary carcinoma to an acoustic neuroma: report of a case. J Neurosurg 1962;19:1088-1093
  59. Altinoz MA, Santaguida C, Guiot MC, Del Maestro RF: Spinal hemangioblastoma containing metastatic renal cell carcinoma in von Hippel-Lindau disease: case report and review of the literature. J Neurosurg Spine 2005;3:495-500
  60. Jarrell ST, Vortmeyer AO, Linehan WM, Oldfield EH, Lonser RR: Metastases to hemangioblastomas in von Hippel-Lindau disease. J Neurosurg 2006;105:256-263
  61. Mork SJ, Rubinstein LJ: Metastatic carcinoma to glioma: a report of three cases with a critical review of the literature. J Neurol Neurosurg Psychiatry 1988;51:256-259
  62. Pal D, Bhargava D, Bucur SD, Shivane A, Chakrabarty A, Van Hille P: Metastatic malignant melanoma within meningioma with intratumoral infarct: report of an unusual case and literature review. Clin Neuropathol 2010;29:105-108
  63. Tsunoo M, Meoded A, Bonetti M, Gasparotti R: MR imaging of metastatic renal cell carcinoma to a meningioma. J Neuroradiol 2010;37:248-250
  64. Chaturvedi S, Gupta S, Kumari R: Meningioma with metastasis from follicular carcinoma thyroid. Indian I Pathol Microbiol 2010;53:316-318
  65. Kano T, Ikota H, Kobayashi S, Iwasa S, Kurosaki S, Wada H: Malignant transformation of an intracranial large epidermoid cyst with leptomeningeal carcinomatosis: case report. Neurol Med Chir (Tokyo) 2010;50:349-353
  66. Vannucci RC, Baten M: Cerebral metastatic disease in childhood. Neurology 1974;24:981-985
  67. Graus F, Walker RW, Allen JC: Brain metastases in children. J Pediatr 1983;103:558-561
  68. Bouffet E, Doumi N, Thiesse P, et al: Brain metastases in children with solid tumors. Cancer 1997;79:403-410
  69. Kalkanis SN, Kondziolka D, Gaspar LE, et al: The role of surgical resection in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 2010;96:33-43
  70. National Lung Screening Trial Research Team: Aberle DR, Berg CD, Black WC, Church TR, Fagerstrom RM, Galen B, Gareen IF, Gatsonis C, Goldin J, Gohagan JK, Hillman B, Jaffe C, Kramer BS, Lynch D, Marcus PM, Schnall M, Sullivan DC, Sullivan D, Zylak CJ: The National Lung Screening Trial: overview and study design. Radiology 2011;258:243-253


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50